scispace - formally typeset
R

Ron Loewenthal

Researcher at Sheba Medical Center

Publications -  44
Citations -  2165

Ron Loewenthal is an academic researcher from Sheba Medical Center. The author has contributed to research in topics: Human leukocyte antigen & Population. The author has an hindex of 24, co-authored 41 publications receiving 2027 citations. Previous affiliations of Ron Loewenthal include Tel Aviv University.

Papers
More filters
Journal ArticleDOI

Donor-Derived Brain Tumor Following Neural Stem Cell Transplantation in an Ataxia Telangiectasia Patient

TL;DR: The findings here suggest that neuronal stem/progenitor cells may be involved in gliomagenesis and provide the first example of a donor-derived brain tumor complicating neural stem cell therapy.
Journal ArticleDOI

Prevalence, causes and characterization of factor XI inhibitors in patients with inherited factor XI deficiency

TL;DR: The results imply that patients with a very low factor XI level are susceptible to development of an inhibitor following plasma replacement, and acquired inhibitors against factor XI are related to specific mutations, and characterize their activity.
Journal ArticleDOI

TMPRSS2/ERG promotes epithelial to mesenchymal transition through the ZEB1/ZEB2 axis in a prostate cancer model.

TL;DR: Using immortalized prostate epithelial cells, it is shown that TMPRSS2/ERG over-expressing cells undergo an Epithelial to Mesenchymal Transition (EMT), manifested by acquisition of mesenchymic morphology and markers as well as migration and invasion capabilities.
Journal ArticleDOI

Modulation of adiponectin and leptin during refeeding of female anorexia nervosa patients.

TL;DR: This study demonstrates hyperadiponectinemia, increased adiponectin HMW isoform, and increased insulin sensitivity in adolescent AN female patients and reversal of these findings with weight rehabilitation.
Journal ArticleDOI

HLA-G is associated with pemphigus vulgaris in Jewish patients.

TL;DR: In this article, a set of 26 SNP markers, which span a chromosomal region of about 600,000 bp, were used to screen DNA samples of the patients and their matched controls.